Evidence map›Paper›PMID 34891158›Full record

ReviewBriefings in bioinformatics2022

A tale of solving two computational challenges in protein science: neoantigen prediction and protein structure prediction.

Ngoc Hieu Tran, Jinbo Xu, Ming Li

Abstract readReview
In one paragraph

Review in Briefings in bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ngoc Hieu TranUniversity of Waterloo, Canada.ORCID 0000-0001-5186-8852
Jinbo XuToyota Technological Institute at Chicago, USA.
Ming LiUniversity of Waterloo, Canada.

Funding

New Computational Methods for Data-driven Protein Structure PredictionR01GM089753 · NIGMS · TOYOTA TECHNOLOGICAL INSTITUTE / CHICAGO · PI XU, JINBO · 2010 to 2023
$3.8M
NIGMS NIH HHS R01 GM089753
6 · The paper itself

Abstract

In this article, we review two challenging computational questions in protein science: neoantigen prediction and protein structure prediction. Both topics have seen significant leaps forward by deep learning within the past five years, which immediately unlocked new developments of drugs and immunotherapies. We show that deep learning models offer unique advantages, such as representation learning and multi-layer architecture, which make them an ideal choice to leverage a huge amount of protein sequence and structure data to address those two problems. We also discuss the impact and future possibilities enabled by those two applications, especially how the data-driven approach by deep learning shall accelerate the progress towards personalized biomedicine.

Indexed as

Deep LearningAmino Acid SequenceImmunotherapyProteinsProteinsdeep learningneoantigen predictionprotein structure prediction

Identifiers

PMID34891158
PMCPMC8769896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.